The Impact of Postoperative Prophylactic Medication on Long-Term Surgical, Severe Endoscopic and Endoscopic or Radiologic Recurrence Following Primary Ileocecal Resection in Patients With Crohn's Disease

IF 6.6 1区医学 Q1 GASTROENTEROLOGY & HEPATOLOGY

Alimentary Pharmacology & Therapeutics Pub Date : 2025-01-24 DOI:10.1111/apt.18496

Sebastiaan ten Bokkel Huinink, Michiel T. J. Bak, Evelien M. J. Beelen, Nicole S. Erler, Mark S. Silverberg, Matthieu Allez, Frank Hoentjen, Alexander G. L. Bodelier, Gerard Dijkstra, Marielle Romberg-Camps, Nanne K. H. de Boer, Laurents P. S. Stassen, Andrea E. van der Meulen – de Jong, Rachel L. West, C. Janneke van der Woude, Oddeke van Ruler, Annemarie C. de Vries

引用次数: 0

Abstract

The impact of prophylactic medication following ileocecal resection (ICR) for Crohn's disease (CD) merits further elucidation. Prophylactic medication following ileocecal resection (ICR) is recommended in patients with Crohn’s disease (CD), particularly in patients at increased risk of recurrence, but the impact on long-term outcomes needs to be further elucidated.

Abstract Image

查看原文本刊更多论文

求助全文

约1分钟内获得全文求助全文

来源期刊

Alimentary Pharmacology & Therapeutics 医学-胃肠肝病学

CiteScore

15.60

自引率

7.90%

发文量

527

审稿时长

3-6 weeks

期刊介绍： Alimentary Pharmacology & Therapeutics is a global pharmacology journal focused on the impact of drugs on the human gastrointestinal and hepato-biliary systems. It covers a diverse range of topics, often with immediate clinical relevance to its readership.